• Molecular NameHomatropine Methylbromide
  • SynonymNA
  • Weight290.383
  • Drugbank_IDDB00725
  • ACS_NO80-49-9
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-1.6
  • pkaN/A
  • LogD (pH=7, predicted)-1.6
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-0.16
  • LogSw (predicted, AB/LogsW2.0)357.87
  • Sw (mg/ml) (predicted, ACD/Labs)202.52
  • No.of HBond Donors1
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds4
  • TPSA46.53
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn anticholinergic medication that inhibits muscarinic acetylcholine receptors and thus the parasympathetic nervous system. It is used in eye drops as a cycloplegic, to temporarily paralyze accommodation, and as a mydriatic, to dilate the pupil.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A